+987.9%
MRNA vs ENPH
+8.1%
+979.8%
-34.2%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 1y.
| Period | Portfolio | ENPH | Excess | Alpha |
|---|---|---|---|---|
| 1D | +13.1% | +3.7% | +9.4% | +12.2% |
| 7D | +20.6% | +26.3% | -5.6% | +13.7% |
| 30D | +27.1% | -5.7% | +32.8% | +28.3% |
| 3M | +353.4% | -24.5% | +377.8% | +381.5% |
| 6M | +446.3% | -3.0% | +449.3% | +449.6% |
| YTD | +776.2% | -1.6% | +777.7% | +745.6% |
| 1Y | +987.9% | +8.8% | +979.2% | +932.9% |
| All | +987.9% | +8.1% | +979.8% | +932.9% |
Cumulative growth
Daily Returns
Daily percentage return beside ENPH.
Daily Out/Under-Performance
Portfolio return minus ENPH return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × ENPH return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 1y: compounded portfolio wealth divided by compounded ENPH wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
1y analysis · Full analysis span regression · 6 months rolling